Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1368 ARTÍCULOS , VIENDO DEL 841 AL 855

Retinal Microvascular and Neurodegenerative Changes in Alzheimer's Disease and Mild Cognitive Impairment Compared with Control Participants

Yoon SP, Grewal DS, Thompson AC, Polascik BW, Dunn C, Burke JR, Fekrat S.

Ophthalmol Retina. 2019 Jun;3(6):489-499. doi: 10.1016/j.oret.2019.02.002. Epub 2019 Mar 11.

Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer's disease

Najm R, Jones EA, Huang Y.

Mol Neurodegener. 2019 Jun 11;14(1):24. doi: 10.1186/s13024-019-0324-6.

Tetrahydrocannabinol Has Potential for Treating Agitation in Alzheimer's Disease

Rosenberg PB, Outen JD, Amjad H, Burhanullah MH, Vandrey R, Monette PJ, Forester BP.

Am J Geriatr Psychiatry. 2019 Nov;27(11):1174-1176. doi: 10.1016/j.jagp.2019.05.014. Epub 2019 May 24.

Commentary on "When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram"

Pollock BG.

Am J Geriatr Psychiatry. 2019 Oct;27(10):1108-1109. doi: 10.1016/j.jagp.2019.05.016. Epub 2019 May 27.

Development of a mnemonic discrimination task using naturalistic stimuli with applications to aging and preclinical Alzheimer's disease

Leal SL, Ferguson LA, Harrison TM, Jagust WJ.

Learn Mem. 2019 Jun 17;26(7):219-228. doi: 10.1101/lm.048967.118. Print 2019 Jul.

Mitochondria- and Oxidative Stress-Targeting Substances in Cognitive Decline-Related Disorders: From Molecular Mechanisms to Clinical Evidence

Lejri I, Agapouda A, Grimm A, Eckert A.

Oxid Med Cell Longev. 2019 May 12;2019:9695412. doi: 10.1155/2019/9695412. eCollection 2019.

Influence of controlled encoding and retrieval facilitation on memory performance of patients with subcortical ischemic vascular dementia and Alzheimer's disease

Perri R, Monaco M, Fadda L, Caltagirone C, Carlesimo GA.

J Neurol. 2019 Oct;266(10):2447-2456. doi: 10.1007/s00415-019-09411-z. Epub 2019 Jun 18.

Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imaging

Brueggen K, Dyrba M, Cardenas-Blanco A, Schneider A, Fliessbach K, Buerger K, Janowitz D, Peters O, Menne F, Priller J, Spruth E, Wiltfang J, Vukovich R, Laske C, Buchmann M, Wagner M, Röske S, Spottke A, Rudolph J, Metzger CD, Kilimann I, Dobisch L, Düzel E, Jessen F, Teipel SJ; DELCODE Study Group.

J Neurol. 2019 Oct;266(10):2465-2474. doi: 10.1007/s00415-019-09429-3. Epub 2019 Jun 21.

Three months of multimodal training contributes to mobility and executive function in elderly individuals with mild cognitive impairment, but not in those with Alzheimer's disease: A randomized controlled trial

de Oliveira Silva F, Ferreira JV, Plácido J, Sant'Anna P, Araújo J, Marinho V, Laks J, Camaz Deslandes A.

Maturitas. 2019 Aug;126:28-33. doi: 10.1016/j.maturitas.2019.04.217. Epub 2019 Apr 27.

Dietary pattern in relation to the risk of Alzheimer's disease: a systematic review

Samadi M, Moradi S, Moradinazar M, Mostafai R, Pasdar Y.

Neurol Sci. 2019 Oct;40(10):2031-2043. doi: 10.1007/s10072-019-03976-3. Epub 2019 Jun 25.

Social Engagement and Amyloid-β-Related Cognitive Decline in Cognitively Normal Older Adults

Biddle KD, d'Oleire Uquillas F, Jacobs HIL, Zide B, Kirn DR, Rentz DM, Johnson KA, Sperling RA, Donovan NJ.

Am J Geriatr Psychiatry. 2019 Nov;27(11):1247-1256. doi: 10.1016/j.jagp.2019.05.005. Epub 2019 May 10.

Comparison of different MRI-based morphometric estimates for defining neurodegeneration across the Alzheimer's disease continuum

Allison SL, Koscik RL, Cary RP, Jonaitis EM, Rowley HA, Chin NA, Zetterberg H, Blennow K, Carlsson CM, Asthana S, Bendlin BB, Johnson SC.

Neuroimage Clin. 2019;23:101895. doi: 10.1016/j.nicl.2019.101895. Epub 2019 Jun 10.

Long-Term Impact of Intelligent Monitoring Technology on People with Cognitive Impairment: An Observational Study

Lazarou I, Stavropoulos TG, Meditskos G, Andreadis S, Kompatsiaris IY, Tsolaki M.

J Alzheimers Dis. 2019;70(3):757-792. doi: 10.3233/JAD-190423.

Proton pump inhibitor use does not increase dementia and Alzheimer's disease risk: An updated meta-analysis of published studies involving 642305 patients

Song YQ, Li Y, Zhang SL, Gao J, Feng SY.

PLoS One. 2019 Jul 2;14(7):e0219213. doi: 10.1371/journal.pone.0219213. eCollection 2019.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias